23 May 2012
The Ethical Standards in Health and Life Sciences Group (ESHLSG) has today (23 May 2012) published a new series of Clinical Trial Transparency Principles and Facts.
This is the first time that leading healthcare professional bodies and senior representatives of the pharmaceutical industry have agreed to a joint approach on this critical issue. This is an important step forward in the on-going move across the entire research community to drive best practice in clinical research reporting.
The ESHLSG Principles document will be introduced, at today’s joint British Medical Journal (BMJ) and Association of the British Pharmaceutical Industry (ABPI) conference: Innovation in research methods and dissemination - ensuring best practice.
BPS are co-signatories of these new clinical trials transparency principles.